HUP0000968A3 - Antigestagenic steroids with a fluorinated 17alpha-alkyl chain - Google Patents

Antigestagenic steroids with a fluorinated 17alpha-alkyl chain

Info

Publication number: HUP0000968A3
Authority: HU; Hungary
Prior art keywords: antigestagenic; 17alpha; steroids; fluorinated; alkyl chain
Prior art date: 1997-02-07

Application number

HU0000968A

Other languages

English (en)

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-07

Filing date

1998-02-09

Publication date

2001-03-28

1998-02-09 Application filed by Schering Ag filed Critical Schering Ag

2000-10-28 Publication of HUP0000968A2 publication Critical patent/HUP0000968A2/hu

2001-03-28 Publication of HUP0000968A3 publication Critical patent/HUP0000968A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Toxicology (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HU0000968A 1997-02-07 1998-02-09 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain HUP0000968A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19706061A DE19706061A1 (de)	1997-02-07	1997-02-07	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
PCT/EP1998/000752 WO1998034947A1 (de)	1997-02-07	1998-02-09	ANTIGESTAGEN WIRKSAME STEROIDE MIT FLUORIERTER 17α-ALKYLKETTE

Publications (2)

Publication Number	Publication Date
HUP0000968A2 HUP0000968A2 (hu)	2000-10-28
HUP0000968A3 true HUP0000968A3 (en)	2001-03-28

Family

ID=7820508

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0000968A HUP0000968A3 (en)	1997-02-07	1998-02-09	Antigestagenic steroids with a fluorinated 17alpha-alkyl chain

Country Status (35)

Country	Link
US (4)	US6316432B1 (hu)
EP (1)	EP0970103B1 (hu)
JP (1)	JP4324249B2 (hu)
KR (1)	KR100511815B1 (hu)
CN (2)	CN1246865A (hu)
AR (1)	AR010887A1 (hu)
AT (1)	ATE216397T1 (hu)
AU (1)	AU742834B2 (hu)
BG (1)	BG63875B1 (hu)
BR (1)	BR9807667A (hu)
CA (1)	CA2280041C (hu)
CL (1)	CL2004001191A1 (hu)
CZ (1)	CZ296328B6 (hu)
DE (2)	DE19706061A1 (hu)
DK (1)	DK0970103T3 (hu)
EA (1)	EA003092B1 (hu)
EE (1)	EE03831B1 (hu)
ES (1)	ES2175673T3 (hu)
HK (1)	HK1040718B (hu)
HU (1)	HUP0000968A3 (hu)
ID (1)	ID22643A (hu)
IL (1)	IL131226A (hu)
IS (1)	IS2190B (hu)
MY (1)	MY118508A (hu)
NO (1)	NO313554B1 (hu)
NZ (1)	NZ336989A (hu)
PL (1)	PL191808B1 (hu)
PT (1)	PT970103E (hu)
SI (1)	SI0970103T1 (hu)
SK (1)	SK283155B6 (hu)
TR (1)	TR199901855T2 (hu)
TW (1)	TW499434B (hu)
UA (1)	UA66783C2 (hu)
WO (1)	WO1998034947A1 (hu)
ZA (1)	ZA98985B (hu)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19706061A1 (de) *	1997-02-07	1998-08-13	Schering Ag	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE10049736A1 (de) *	2000-09-29	2002-04-18	Jenapharm Gmbh	17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
UY26965A1 (es) *	2000-10-18	2002-06-20	Schering Ag	Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
CN1311833C (zh) *	2000-10-18	2007-04-25	舍林股份公司	肿瘤细胞生长因子依赖性的抑制
PL360151A1 (en) *	2000-10-18	2004-09-06	Schering Aktiengesellschaft	Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
HUP0301433A3 (en) *	2000-10-18	2010-01-28	Schering Ag	Use of antiprogestins for producung pharmaceutical compositions for induction of apoptosis in a cell
DE10051609A1 (de) *	2000-10-18	2002-05-02	Schering Ag	Hemmung der Wachstumsfaktorabhängigkeit von Tumorzellen
UY26966A1 (es) *	2000-10-18	2002-06-20	Schering Ag	Uso de antiprogestinas para la inducción de apoptosis en una célula
SK8612003A3 (en) *	2001-01-09	2004-03-02	Schering Ag	The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
US20020143000A1 (en) *	2001-01-09	2002-10-03	Christa Hegele-Hartung	Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
UY27301A1 (es) *	2001-05-25	2003-02-28	Schering Ag	Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
US20030013694A1 (en) *	2001-05-25	2003-01-16	Jens Hoffmann	Use and compositions of antiprogestins for treatment of prostate diseases
DE10159217A1 (de)	2001-11-27	2003-06-05	Schering Ag	17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
DE50301507D1 (de) *	2002-05-03	2005-12-01	Schering Ag	17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
DE10221034A1 (de) *	2002-05-03	2003-11-20	Schering Ag	17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US20040242551A1 (en) *	2003-05-28	2004-12-02	Schering Ag	Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
EA010485B1 (ru)	2003-07-23	2008-10-30	Байер Фамэсьютиклс Копэрейшн	Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
US7593347B2 (en) *	2003-12-29	2009-09-22	Intel Corporation	Method and apparatus to exchange channel information
EP1862468A1 (de) *	2006-06-02	2007-12-05	Bayer Schering Pharma Aktiengesellschaft	Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
ES2814343T3 (es)	2006-10-24	2021-03-26	Allergan Pharmaceuticals Int Ltd	Composiciones y métodos para suprimir las proliferaciones endometriales
DE102006054535A1 (de) *	2006-11-15	2008-05-21	Bayer Schering Pharma Aktiengesellschaft	Progesteronrezeptorantagonisten
US20090029954A1 (en) *	2007-04-23	2009-01-29	Jens Hoffmann	Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
US20080268041A1 (en) *	2007-04-23	2008-10-30	Jens Hoffmann	Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
TWI539953B (zh)	2008-04-28	2016-07-01	瑞波若斯治療學公司	用於治療乳癌之組成物和方法
EP2123279A1 (de) *	2008-05-14	2009-11-25	Bayer Schering Pharma Aktiengesellschaft	Sequentielle Verabreichung von 20,20,21,21,21-Pentafluor-17-hydroxy-1 1beta-[4-(hydroxyacetyl) phenyl]-19-nor-17alpha-pregna-4,9-dien-3-on und einem oder mehreren Gestagenen zur Behandlung gynäkologischer Erkrankungen
US20100087402A1 (en) *	2008-09-29	2010-04-08	Vivus, Inc.	Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
DE102009034368A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) *	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de)	2009-07-21	2011-02-10	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de)	2009-07-21	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
DE102010007719A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
US20130018027A1 (en)	2010-03-22	2013-01-17	Repros Therapeutics Inc.	Compositions and methods for non-toxic delivery of antiprogestins
DE102010030538A1 (de)	2010-06-25	2011-12-29	Bayer Schering Pharma Aktiengesellschaft	6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE102011004899A1 (de)	2011-03-01	2012-09-06	Bayer Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) *	2011-07-28	2013-01-31	Klaus Nickisch	Progesterone antagonists
DE102011087987A1 (de)	2011-12-08	2013-06-13	Bayer Intellectual Property Gmbh	6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
MA38465A1 (fr)	2013-04-11	2017-02-28	Bayer Pharma AG	Forme posologique de l'antagoniste du récepteur de la progestérone
US9096641B2 (en)	2013-06-05	2015-08-04	Evestra, Inc.	Imidazolyl progesterone antagonists
EP2868321A1 (en)	2013-11-03	2015-05-06	Flamina Holding AG	A composition or group of compositions for inhibiting autocrine HCG production in adult human cells
US9603856B2 (en)	2013-11-03	2017-03-28	Flamina Holding Ag	Pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells
HK1245118A1 (zh)	2015-05-18	2018-08-24	Bayer Pharma Aktiengesellschaft	选择性孕酮受体调节剂(sprm)方案
EP3214092A1 (en)	2016-03-04	2017-09-06	Bayer Pharma Aktiengesellschaft	Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE310541C (hu) *	1915-12-19	1919-01-30
ZA8231B (en) *	1981-01-09	1982-11-24	Roussel Uclaf	New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2639045B2 (fr)	1982-03-01	1994-07-29	Roussel Uclaf	Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
US5064821A (en) *	1982-11-18	1991-11-12	Trustees Of Tufts College	Method and compositions for overcoming tetracycline resistance within living cells
FR2598421B1 (fr)	1986-05-06	1988-08-19	Roussel Uclaf	Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US5272140A (en) *	1987-01-23	1993-12-21	Akzo N.V.	11-aryl steroid derivatives
DE3723788A1 (de) *	1987-07-16	1989-01-26	Schering Ag	11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3733478A1 (de)	1987-10-01	1989-04-13	Schering Ag	Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
JP2785023B2 (ja) *	1987-12-30	1998-08-13	ルセル―ユクラフ	１７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
EP0369881A1 (fr) *	1988-11-16	1990-05-23	Roussel-Uclaf	Nouveaux produits dérivés de la structure 3-céto delta-4,9 19-nor stéroides et leur application comme médicaments
DE3921059A1 (de) *	1989-06-23	1991-01-10	Schering Ag	11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
CN1055929C (zh) *	1993-09-20	2000-08-30	中国科学院上海有机化学研究所	三氟甲基甾体化合物及其制备方法
DE19706061A1 (de) *	1997-02-07	1998-08-13	Schering Ag	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

1997
- 1997-02-07 DE DE19706061A patent/DE19706061A1/de not_active Withdrawn
1998
- 1998-02-06 MY MYPI98000482A patent/MY118508A/en unknown
- 1998-02-06 ZA ZA9800985A patent/ZA98985B/xx unknown
- 1998-02-07 TW TW087101642A patent/TW499434B/zh not_active IP Right Cessation
- 1998-02-09 TR TR1999/01855T patent/TR199901855T2/xx unknown
- 1998-02-09 EE EEP199900339A patent/EE03831B1/xx not_active IP Right Cessation
- 1998-02-09 CZ CZ0280599A patent/CZ296328B6/cs not_active IP Right Cessation
- 1998-02-09 DE DE59803856T patent/DE59803856D1/de not_active Expired - Lifetime
- 1998-02-09 SI SI9830200T patent/SI0970103T1/xx unknown
- 1998-02-09 NZ NZ336989A patent/NZ336989A/en not_active IP Right Cessation
- 1998-02-09 JP JP53378598A patent/JP4324249B2/ja not_active Expired - Fee Related
- 1998-02-09 WO PCT/EP1998/000752 patent/WO1998034947A1/de not_active Ceased
- 1998-02-09 HU HU0000968A patent/HUP0000968A3/hu unknown
- 1998-02-09 AR ARP980100532A patent/AR010887A1/es unknown
- 1998-02-09 EA EA199900644A patent/EA003092B1/ru not_active IP Right Cessation
- 1998-02-09 DK DK98905419T patent/DK0970103T3/da active
- 1998-02-09 CA CA002280041A patent/CA2280041C/en not_active Expired - Fee Related
- 1998-02-09 ID IDW990831A patent/ID22643A/id unknown
- 1998-02-09 SK SK1038-99A patent/SK283155B6/sk not_active IP Right Cessation
- 1998-02-09 PL PL334878A patent/PL191808B1/pl not_active IP Right Cessation
- 1998-02-09 KR KR10-1999-7007098A patent/KR100511815B1/ko not_active Expired - Fee Related
- 1998-02-09 EP EP98905419A patent/EP0970103B1/de not_active Expired - Lifetime
- 1998-02-09 IL IL13122698A patent/IL131226A/en not_active IP Right Cessation
- 1998-02-09 ES ES98905419T patent/ES2175673T3/es not_active Expired - Lifetime
- 1998-02-09 AU AU61005/98A patent/AU742834B2/en not_active Ceased
- 1998-02-09 AT AT98905419T patent/ATE216397T1/de active
- 1998-02-09 CN CN98802361A patent/CN1246865A/zh active Pending
- 1998-02-09 PT PT98905419T patent/PT970103E/pt unknown
- 1998-02-09 BR BR9807667-1A patent/BR9807667A/pt active Search and Examination
- 1998-02-09 UA UA99094999A patent/UA66783C2/xx unknown
1999
- 1999-07-26 BG BG103603A patent/BG63875B1/bg unknown
- 1999-08-04 IS IS5147A patent/IS2190B/is unknown
- 1999-08-06 NO NO19993811A patent/NO313554B1/no not_active IP Right Cessation
2000
- 2000-03-01 US US09/516,359 patent/US6316432B1/en not_active Expired - Fee Related
- 2000-09-25 CN CNB001290150A patent/CN1202120C/zh not_active Expired - Fee Related
2001
- 2001-10-18 US US09/978,689 patent/US6503895B2/en not_active Expired - Fee Related
2002
- 2002-04-08 HK HK02102580.0A patent/HK1040718B/zh not_active IP Right Cessation
- 2002-11-27 US US10/304,742 patent/US6806263B2/en not_active Expired - Fee Related
2004
- 2004-05-20 CL CL200401191A patent/CL2004001191A1/es unknown
- 2004-09-24 US US10/948,652 patent/US7148213B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
MY118508A (en)	2004-11-30
KR100511815B1 (ko)	2005-09-05
CN1324802A (zh)	2001-12-05
CL2004001191A1 (es)	2005-03-28
BG63875B1 (bg)	2003-04-30
US20050080060A1 (en)	2005-04-14
IL131226A0 (en)	2001-01-28
JP4324249B2 (ja)	2009-09-02
TR199901855T2 (xx)	2000-04-21
EP0970103B1 (de)	2002-04-17
EA199900644A1 (ru)	2000-04-24
AR010887A1 (es)	2000-07-12
EE9900339A (et)	2000-02-15
ES2175673T3 (es)	2002-11-16
US7148213B2 (en)	2006-12-12
CN1246865A (zh)	2000-03-08
CA2280041A1 (en)	1998-08-13
PL334878A1 (en)	2000-03-27
NO313554B1 (no)	2002-10-21
US6316432B1 (en)	2001-11-13
NO993811L (no)	1999-10-04
DE59803856D1 (de)	2002-05-23
EE03831B1 (et)	2002-08-15
AU742834B2 (en)	2002-01-10
EP0970103A1 (de)	2000-01-12
HUP0000968A2 (hu)	2000-10-28
NZ336989A (en)	2001-04-27
CN1202120C (zh)	2005-05-18
ZA98985B (en)	1999-08-03
HK1040718B (zh)	2005-12-09
BG103603A (en)	2000-06-30
HK1040718A1 (en)	2002-06-21
DK0970103T3 (da)	2002-07-22
SK103899A3 (en)	2000-05-16
PL191808B1 (pl)	2006-07-31
TW499434B (en)	2002-08-21
US20030134834A1 (en)	2003-07-17
IL131226A (en)	2004-12-15
IS2190B (is)	2007-01-15
ID22643A (id)	1999-12-02
UA66783C2 (en)	2004-06-15
EA003092B1 (ru)	2002-12-26
KR20000070835A (ko)	2000-11-25
CA2280041C (en)	2007-10-23
CZ280599A3 (cs)	2000-01-12
US6806263B2 (en)	2004-10-19
DE19706061A1 (de)	1998-08-13
SK283155B6 (sk)	2003-03-04
US20020045774A1 (en)	2002-04-18
PT970103E (pt)	2002-09-30
BR9807667A (pt)	2000-02-15
IS5147A (is)	1999-08-04
WO1998034947A1 (de)	1998-08-13
US6503895B2 (en)	2003-01-07
JP2001510479A (ja)	2001-07-31
CZ296328B6 (cs)	2006-02-15
NO993811D0 (no)	1999-08-06
SI0970103T1 (en)	2002-10-31
ATE216397T1 (de)	2002-05-15
AU6100598A (en)	1998-08-26

Publication	Publication Date	Title
HUP0000968A3 (en)	2001-03-28	Antigestagenic steroids with a fluorinated 17alpha-alkyl chain
AU6558199A (en)	2003-12-12	A postable sticker
PL360002A1 (en)	2004-09-06	A chain
GB9216280D0 (en)	1992-09-16	Steroids with a fluorinated acylureidic type side chain
GB2323893B (en)	2000-10-11	Chain guide assembly
GB9704222D0 (en)	1997-04-16	A component
GB9713632D0 (en)	1997-09-03	A chain
GB9721016D0 (en)	1997-12-03	A chain
GB9715764D0 (en)	1997-10-01	A chain
AU8448998A (en)	1999-02-16	A chain
GB9610013D0 (en)	1996-07-17	A platform assembly
ZA987035B (en)	1999-02-08	A ladder
AU133724S (en)	1998-05-11	A section
AU131134S (en)	1997-09-12	A section
AU135968S (en)	1998-12-02	A section
AU135926S (en)	1998-12-04	A section
AU132404S (en)	1997-12-09	A section
PL105478U1 (en)	1998-04-27	Tubular rivet with a nicroprint
GB9822632D0 (en)	1998-12-09	A chain
GB9814434D0 (en)	1998-09-02	A chain
GB9415183D0 (en)	1994-09-21	3-carboxysteroids with a fluorinated side-chain
AU132492S (en)	1997-12-16	A light
TW337337U (en)	1998-07-21	A light
AU132788S (en)	1998-02-03	A pareo
AU135496S (en)	1998-10-27	A crumpet

Legal Events

Date	Code	Title	Description
2012-10-29	FA9A	Lapse of provisional patent protection due to relinquishment or protection considered relinquished